(-)-demecolcine increases expression ISO RGD:731339 6480464 Demecolcine results in increased expression of SLC30A1 mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate decreases expression ISO RGD:731339 6480464 epigallocatechin gallate results in decreased expression of SLC30A1 mRNA CTD PMID:20471814 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:731339 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of SLC30A1 mRNA, epigallocatechin gallate inhibits the reaction [zinc chloride results in increased expression of SLC30A1 mRNA] CTD PMID:20471814 , PMID:22079256 1,2-dichloroethane decreases expression ISO RGD:62211 6480464 ethylene dichloride results in decreased expression of SLC30A1 mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression ISO RGD:62211 6480464 1, 2-Dimethylhydrazine results in decreased expression of SLC30A1 mRNA CTD PMID:22206623 1-(5-isoquinolinesulfonyl)-2-methylpiperazine multiple interactions ISO RGD:62211 6480464 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Cadmium Chloride results in increased expression of SLC30A1 mRNA], 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Zinc Sulfate results in increased expression of SLC30A1 mRNA] CTD PMID:15142038 17alpha-ethynylestradiol increases expression ISO RGD:62211 6480464 Ethinyl Estradiol results in increased expression of SLC30A1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects expression ISO RGD:731339 6480464 Ethinyl Estradiol affects the expression of SLC30A1 mRNA CTD PMID:20170705 , PMID:26865667 17alpha-ethynylestradiol multiple interactions ISO RGD:62211 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC30A1 mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO RGD:731339 6480464 Estradiol results in increased expression of SLC30A1 mRNA CTD PMID:23019147 , PMID:31614463 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:62211 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC30A1 mRNA CTD PMID:15328365 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC30A1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:62211 6480464 Tetrachlorodibenzodioxin affects the expression of SLC30A1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:62211 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC30A1 mRNA CTD PMID:17942748 2-methoxyethanol increases expression EXP 6480464 methyl cellosolve results in increased expression of SLC30A1 mRNA CTD PMID:21061450 5-(2-methylpiperazine-1-sulfonyl)isoquinoline multiple interactions ISO RGD:62211 6480464 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Cadmium Chloride results in increased expression of SLC30A1 mRNA], 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Zinc Sulfate results in increased expression of SLC30A1 mRNA] CTD PMID:15142038 5-aza-2'-deoxycytidine affects expression ISO RGD:731339 6480464 Decitabine affects the expression of SLC30A1 mRNA CTD PMID:23300844 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of SLC30A1 mRNA CTD PMID:31881176 acrylamide increases expression ISO RGD:731339 6480464 Acrylamide results in increased expression of SLC30A1 mRNA CTD PMID:32763439 aflatoxin B1 increases expression ISO RGD:731339 6480464 Aflatoxin B1 results in increased expression of SLC30A1 mRNA CTD PMID:21641981 aflatoxin B1 decreases methylation ISO RGD:731339 6480464 Aflatoxin B1 results in decreased methylation of SLC30A1 gene CTD PMID:27153756 aldehydo-D-glucose increases expression EXP 6480464 Glucose results in increased expression of SLC30A1 mRNA CTD PMID:23056475 aldehydo-D-glucose multiple interactions EXP 6480464 N more ... CTD PMID:23056475 aldosterone multiple interactions EXP 6480464 Spironolactone inhibits the reaction [Aldosterone results in increased expression of SLC30A1 mRNA] CTD PMID:19333130 aldosterone increases expression EXP 6480464 Aldosterone results in increased expression of SLC30A1 mRNA CTD PMID:19333130 all-trans-retinoic acid increases expression ISO RGD:731339 6480464 Tretinoin results in increased expression of SLC30A1 protein CTD PMID:30093655 all-trans-retinol decreases expression EXP 6480464 Vitamin A deficiency results in decreased expression of SLC30A1 protein CTD PMID:12421840 AM-251 increases expression ISO RGD:731339 6480464 AM 251 results in increased expression of SLC30A1 mRNA CTD PMID:16500647 amiodarone increases expression ISO RGD:731339 6480464 Amiodarone results in increased expression of SLC30A1 mRNA CTD PMID:19774075 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SLC30A1 mRNA CTD PMID:16483693 antimycin A increases expression ISO RGD:731339 6480464 Antimycin A results in increased expression of SLC30A1 mRNA CTD PMID:33512557 arsenite(3-) increases expression ISO RGD:62211 6480464 arsenite results in increased expression of SLC30A1 mRNA CTD PMID:18929588 arsenite(3-) multiple interactions ISO RGD:731339 6480464 arsenite promotes the reaction [G3BP1 protein binds to SLC30A1 mRNA] CTD PMID:32406909 arsenite(3-) increases expression ISO RGD:731339 6480464 arsenite results in increased expression of SLC30A1 mRNA CTD PMID:32406909 arsenite(3-) multiple interactions ISO RGD:62211 6480464 TRP53 protein affects the reaction [arsenite results in increased expression of SLC30A1 mRNA] CTD PMID:18929588 arsenous acid increases expression ISO RGD:731339 6480464 Arsenic Trioxide results in increased expression of SLC30A1 mRNA, Arsenic Trioxide results in increased expression of SLC30A1 protein CTD PMID:26705709 more ... arsenous acid affects response to substance ISO RGD:731339 6480464 SLC30A1 gene mutant form affects the susceptibility to Arsenic Trioxide CTD PMID:30815697 benzo[a]pyrene increases expression ISO RGD:731339 6480464 Benzo(a)pyrene results in increased expression of SLC30A1 mRNA CTD PMID:20106945 , PMID:21632981 benzo[a]pyrene affects methylation ISO RGD:731339 6480464 Benzo(a)pyrene affects the methylation of SLC30A1 promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO RGD:62211 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC30A1 mRNA CTD PMID:27858113 benzo[a]pyrene increases expression ISO RGD:62211 6480464 Benzo(a)pyrene results in increased expression of SLC30A1 mRNA CTD PMID:21569818 , PMID:22610609 benzo[a]pyrene diol epoxide I increases expression ISO RGD:731339 6480464 7 more ... CTD PMID:20382639 benzo[b]fluoranthene multiple interactions ISO RGD:62211 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC30A1 mRNA CTD PMID:27858113 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:62211 6480464 Diethylhexyl Phthalate results in decreased expression of SLC30A1 mRNA CTD PMID:15294341 bisphenol A affects expression ISO RGD:731339 6480464 bisphenol A affects the expression of SLC30A1 mRNA CTD PMID:20170705 , PMID:30903817 bisphenol A increases expression ISO RGD:731339 6480464 bisphenol A results in increased expression of SLC30A1 mRNA CTD PMID:29275510 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SLC30A1 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:62211 6480464 bisphenol A results in decreased expression of SLC30A1 mRNA CTD PMID:26063408 , PMID:33221593 butan-1-ol multiple interactions ISO RGD:731339 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SLC30A1 mRNA CTD PMID:29432896 cadmium atom increases expression ISO RGD:731339 6480464 Cadmium results in increased expression of SLC30A1 mRNA, Cadmium results in increased expression of SLC30A1 protein CTD PMID:14568174 , PMID:21120746 cadmium atom multiple interactions ISO RGD:731339 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC30A1 mRNA, Cadmium results in increased expression of and affects the localization of SLC30A1 protein CTD PMID:19900532 more ... cadmium atom increases expression ISO RGD:62211 6480464 Cadmium results in increased expression of SLC30A1 CTD PMID:19288494 cadmium atom decreases uptake ISO RGD:62211 6480464 SLC30A1 protein results in decreased uptake of Cadmium CTD PMID:19288494 cadmium atom multiple interactions ISO RGD:62211 6480464 SLC30A1 inhibits the reaction [Cadmium results in increased expression of and results in increased secretion of CLU protein] CTD PMID:19288494 cadmium dichloride affects expression EXP 6480464 Cadmium Chloride affects the expression of SLC30A1 mRNA CTD PMID:22110744 more ... cadmium dichloride multiple interactions ISO RGD:731339 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC30A1 mRNA CTD PMID:29741670 more ... cadmium dichloride decreases expression ISO RGD:62211 6480464 Cadmium Chloride results in decreased expression of SLC30A1 CTD PMID:27319394 cadmium dichloride increases expression ISO RGD:731339 6480464 Cadmium Chloride results in increased expression of SLC30A1 mRNA CTD PMID:18560533 more ... cadmium dichloride multiple interactions ISO RGD:62211 6480464 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Cadmium Chloride results in increased expression of SLC30A1 mRNA] more ... CTD PMID:15142038 cadmium dichloride increases expression ISO RGD:62211 6480464 Cadmium Chloride results in increased expression of SLC30A1 mRNA CTD PMID:10952993 more ... cadmium dichloride multiple interactions EXP 6480464 zinc chloride affects the reaction [Cadmium Chloride affects the expression of SLC30A1 mRNA] CTD PMID:25653005 caffeine decreases phosphorylation ISO RGD:731339 6480464 Caffeine results in decreased phosphorylation of SLC30A1 protein CTD PMID:35688186 calcitriol multiple interactions EXP 6480464 [Calcium co-treated with Calcitriol] affects the expression of SLC30A1 mRNA CTD PMID:15913539 calcitriol increases expression ISO RGD:731339 6480464 Calcitriol results in increased expression of SLC30A1 mRNA CTD PMID:16002434 calcium atom multiple interactions EXP 6480464 [Calcium co-treated with Calcitriol] affects the expression of SLC30A1 mRNA CTD PMID:15913539 calcium(0) multiple interactions EXP 6480464 [Calcium co-treated with Calcitriol] affects the expression of SLC30A1 mRNA CTD PMID:15913539 cannabidiol increases expression ISO RGD:62211 6480464 Cannabidiol results in increased expression of SLC30A1 mRNA CTD PMID:21542829 more ... cannabidiol increases expression ISO RGD:731339 6480464 Cannabidiol results in increased expression of SLC30A1 mRNA CTD PMID:33244087 cannabidiol multiple interactions ISO RGD:62211 6480464 [lipopolysaccharide, E coli O55-B5 co-treated with Cannabidiol] results in increased expression of SLC30A1 mRNA CTD PMID:30742662 CGP 52608 multiple interactions ISO RGD:731339 6480464 CGP 52608 promotes the reaction [RORA protein binds to SLC30A1 gene] CTD PMID:28238834 chrysene multiple interactions ISO RGD:62211 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC30A1 mRNA CTD PMID:27858113 cisplatin increases expression ISO RGD:731339 6480464 Cisplatin results in increased expression of SLC30A1 mRNA CTD PMID:19561079 , PMID:33545341 cisplatin multiple interactions ISO RGD:731339 6480464 [Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of SLC30A1 mRNA CTD PMID:30871063 cisplatin affects expression ISO RGD:731339 6480464 Cisplatin affects the expression of SLC30A1 mRNA CTD PMID:23300844 cobalt dichloride affects expression ISO RGD:731339 6480464 cobaltous chloride affects the expression of SLC30A1 mRNA CTD PMID:17553155 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of SLC30A1 mRNA CTD PMID:24386269 cobalt dichloride increases expression ISO RGD:731339 6480464 cobaltous chloride results in increased expression of SLC30A1 mRNA CTD PMID:19320972 colforsin daropate hydrochloride increases expression ISO RGD:731339 6480464 Colforsin results in increased expression of SLC30A1 mRNA CTD PMID:16503475 copper atom multiple interactions ISO RGD:731339 6480464 [Disulfiram binds to Copper] which results in decreased expression of SLC30A1 mRNA, [NSC 689534 binds to Copper] which results in increased expression of SLC30A1 mRNA CTD PMID:20971185 , PMID:24690739 copper(0) multiple interactions ISO RGD:731339 6480464 [Disulfiram binds to Copper] which results in decreased expression of SLC30A1 mRNA, [NSC 689534 binds to Copper] which results in increased expression of SLC30A1 mRNA CTD PMID:20971185 , PMID:24690739 copper(II) chloride increases expression ISO RGD:731339 6480464 cupric chloride results in increased expression of SLC30A1 mRNA CTD PMID:24343273 copper(II) sulfate increases expression ISO RGD:731339 6480464 Copper Sulfate results in increased expression of SLC30A1 mRNA CTD PMID:19549813 coumestrol decreases expression ISO RGD:731339 6480464 Coumestrol results in decreased expression of SLC30A1 mRNA CTD PMID:19167446 CU-O LINKAGE increases expression ISO RGD:731339 6480464 cupric oxide results in increased expression of SLC30A1 mRNA CTD PMID:24343273 , PMID:32285662 curcumin increases expression ISO RGD:731339 6480464 Curcumin results in increased expression of SLC30A1 mRNA CTD PMID:17999991 D-glucose increases expression EXP 6480464 Glucose results in increased expression of SLC30A1 mRNA CTD PMID:23056475 D-glucose multiple interactions EXP 6480464 N more ... CTD PMID:23056475 D-penicillamine decreases expression EXP 6480464 Penicillamine results in decreased expression of SLC30A1 mRNA CTD PMID:19575532 D-penicillamine increases expression EXP 6480464 Penicillamine results in increased expression of SLC30A1 mRNA CTD PMID:19575532 deguelin increases expression ISO RGD:731339 6480464 deguelin results in increased expression of SLC30A1 mRNA CTD PMID:33512557 dexamethasone decreases expression ISO RGD:62211 6480464 Dexamethasone results in decreased expression of SLC30A1 mRNA CTD PMID:22733784 dextran sulfate multiple interactions ISO RGD:62211 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC30A1 mRNA CTD PMID:29950665 diarsenic trioxide increases expression ISO RGD:731339 6480464 Arsenic Trioxide results in increased expression of SLC30A1 mRNA, Arsenic Trioxide results in increased expression of SLC30A1 protein CTD PMID:26705709 more ... diarsenic trioxide affects response to substance ISO RGD:731339 6480464 SLC30A1 gene mutant form affects the susceptibility to Arsenic Trioxide CTD PMID:30815697 dibenz[a,h]anthracene increases expression ISO RGD:62211 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of SLC30A1 mRNA CTD PMID:21266533 dicoumarol multiple interactions ISO RGD:62211 6480464 Dicumarol inhibits the reaction [Cadmium Chloride results in increased expression of SLC30A1 mRNA], Dicumarol inhibits the reaction [Zinc Sulfate results in increased expression of SLC30A1 mRNA] CTD PMID:15142038 dicrotophos decreases expression ISO RGD:731339 6480464 dicrotophos results in decreased expression of SLC30A1 mRNA CTD PMID:28302478 disulfiram multiple interactions ISO RGD:731339 6480464 [Disulfiram binds to Copper] which results in decreased expression of SLC30A1 mRNA CTD PMID:24690739 diuron increases expression EXP 6480464 Diuron results in increased expression of SLC30A1 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:731339 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin affects expression ISO RGD:731339 6480464 Doxorubicin affects the expression of SLC30A1 mRNA CTD PMID:25529476 elesclomol multiple interactions ISO RGD:731339 6480464 Acetylcysteine inhibits the reaction [elesclomol results in increased expression of SLC30A1 mRNA] CTD PMID:18723479 elesclomol increases expression ISO RGD:731339 6480464 elesclomol results in increased expression of SLC30A1 mRNA CTD PMID:18723479 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of SLC30A1 mRNA CTD PMID:29391264 epoxiconazole decreases expression ISO RGD:62211 6480464 epoxiconazole results in decreased expression of SLC30A1 mRNA CTD PMID:35436446 ethyl methanesulfonate increases expression ISO RGD:731339 6480464 Ethyl Methanesulfonate results in increased expression of SLC30A1 mRNA CTD PMID:23649840 flurotyl decreases expression EXP 6480464 Flurothyl results in decreased expression of SLC30A1 mRNA CTD PMID:19059322 , PMID:20167268 formaldehyde increases expression ISO RGD:731339 6480464 Formaldehyde results in increased expression of SLC30A1 mRNA CTD PMID:23649840 genistein increases expression ISO RGD:731339 6480464 Genistein results in increased expression of SLC30A1 mRNA CTD PMID:18847459 , PMID:23019147 genistein affects expression ISO RGD:731339 6480464 Genistein affects the expression of SLC30A1 mRNA CTD PMID:26865667 genistein 7-O-beta-D-glucoside increases expression ISO RGD:731339 6480464 genistin analog results in increased expression of SLC30A1 mRNA CTD PMID:16719502 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of SLC30A1 mRNA CTD PMID:33387578 glucose increases expression EXP 6480464 Glucose results in increased expression of SLC30A1 mRNA CTD PMID:23056475 glucose multiple interactions EXP 6480464 N more ... CTD PMID:23056475 irinotecan decreases expression ISO RGD:731339 6480464 Irinotecan analog results in decreased expression of SLC30A1 mRNA CTD PMID:18927307 isotretinoin decreases expression ISO RGD:731339 6480464 Isotretinoin results in decreased expression of SLC30A1 mRNA CTD PMID:20436886 ivermectin decreases expression ISO RGD:731339 6480464 Ivermectin results in decreased expression of SLC30A1 protein CTD PMID:32959892 lead diacetate increases expression ISO RGD:62211 6480464 lead acetate results in increased expression of SLC30A1 mRNA CTD PMID:25270620 leflunomide increases expression ISO RGD:731339 6480464 leflunomide results in increased expression of SLC30A1 mRNA CTD PMID:28988120 lipopolysaccharide increases expression ISO RGD:62211 6480464 Lipopolysaccharides results in increased expression of SLC30A1 mRNA, Lipopolysaccharides results in increased expression of SLC30A1 protein CTD PMID:16892068 , PMID:17126599 lipopolysaccharide multiple interactions ISO RGD:62211 6480464 TICAM1 protein affects the reaction [Lipopolysaccharides results in increased expression of SLC30A1 protein] CTD PMID:16892068 mercury atom increases expression EXP 6480464 Mercury results in increased expression of SLC30A1 mRNA CTD PMID:12730625 mercury dibromide increases expression ISO RGD:731339 6480464 mercuric bromide results in increased expression of SLC30A1 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:731339 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC30A1 mRNA CTD PMID:27188386 mercury dichloride increases expression EXP 6480464 Mercuric Chloride results in increased expression of SLC30A1 mRNA CTD PMID:16507785 mercury(0) increases expression EXP 6480464 Mercury results in increased expression of SLC30A1 mRNA CTD PMID:12730625 methyl methanesulfonate increases expression ISO RGD:731339 6480464 Methyl Methanesulfonate results in increased expression of SLC30A1 mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO RGD:731339 6480464 methylmercuric chloride results in increased expression of SLC30A1 mRNA CTD PMID:32870474 motexafin gadolinium increases expression ISO RGD:731339 6480464 motexafin gadolinium results in increased expression of SLC30A1 mRNA CTD PMID:15867382 , PMID:16357179 motexafin gadolinium multiple interactions ISO RGD:731339 6480464 [Zinc co-treated with motexafin gadolinium] results in increased expression of SLC30A1 mRNA more ... CTD PMID:15867382 , PMID:16357179 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine decreases expression ISO RGD:731339 6480464 N more ... CTD PMID:12756304 , PMID:19720134 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine multiple interactions EXP 6480464 N more ... CTD PMID:23056475 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine multiple interactions ISO RGD:731339 6480464 [Zinc co-treated with N more ... CTD PMID:17018880 , PMID:19720134 N-acetyl-L-cysteine multiple interactions ISO RGD:731339 6480464 Acetylcysteine inhibits the reaction [elesclomol results in increased expression of SLC30A1 mRNA] CTD PMID:18723479 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of SLC30A1 mRNA CTD PMID:24136188 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of SLC30A1 mRNA CTD PMID:22110744 nitroprusside multiple interactions ISO RGD:731339 6480464 N more ... CTD PMID:17018880 nitroprusside increases expression ISO RGD:731339 6480464 Nitroprusside results in increased expression of SLC30A1 mRNA CTD PMID:17018880 ochratoxin A multiple interactions ISO RGD:731339 6480464 ochratoxin A promotes the reaction [N more ... CTD PMID:19720134 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SLC30A1 mRNA CTD PMID:25729387 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of SLC30A1 mRNA CTD PMID:25729387 p-chloromercuribenzoic acid increases expression ISO RGD:731339 6480464 p-Chloromercuribenzoic Acid results in increased expression of SLC30A1 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:731339 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC30A1 mRNA CTD PMID:27188386 paracetamol affects expression ISO RGD:62211 6480464 Acetaminophen affects the expression of SLC30A1 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of SLC30A1 mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:731339 6480464 Acetaminophen results in decreased expression of SLC30A1 mRNA CTD PMID:26690555 paracetamol increases expression ISO RGD:731339 6480464 Acetaminophen results in increased expression of SLC30A1 mRNA CTD PMID:21420995 paraquat affects expression EXP 6480464 Paraquat affects the expression of SLC30A1 mRNA CTD PMID:18198484 pentetic acid multiple interactions EXP 6480464 Pentetic Acid affects the reaction [SLC30A1 protein affects the transport of Zinc] CTD PMID:21775119 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:731339 6480464 perfluorooctane sulfonic acid results in decreased expression of SLC30A1 mRNA CTD PMID:32790152 perfluorooctanoic acid increases expression ISO RGD:731339 6480464 perfluorooctanoic acid results in increased expression of SLC30A1 mRNA CTD PMID:25868421 perfluorooctanoic acid decreases expression ISO RGD:731339 6480464 perfluorooctanoic acid results in decreased expression of SLC30A1 mRNA CTD PMID:32790152 phenobarbital affects expression ISO RGD:731339 6480464 Phenobarbital affects the expression of SLC30A1 mRNA CTD PMID:19159669 phenylmercury acetate increases expression ISO RGD:731339 6480464 Phenylmercuric Acetate results in increased expression of SLC30A1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:731339 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC30A1 mRNA CTD PMID:27188386 phorone affects expression EXP 6480464 phorone affects the expression of SLC30A1 mRNA CTD PMID:18198479 picoxystrobin increases expression ISO RGD:731339 6480464 picoxystrobin results in increased expression of SLC30A1 mRNA CTD PMID:33512557 pirinixic acid increases expression ISO RGD:62211 6480464 pirinixic acid results in increased expression of SLC30A1 mRNA CTD PMID:18445702 potassium chromate increases expression ISO RGD:731339 6480464 potassium chromate(VI) results in increased expression of SLC30A1 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:731339 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of SLC30A1 mRNA CTD PMID:22079256 propanal increases expression ISO RGD:731339 6480464 propionaldehyde results in increased expression of SLC30A1 mRNA CTD PMID:26079696 protein kinase inhibitor multiple interactions ISO RGD:731339 6480464 Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of SLC30A1 mRNA] CTD PMID:28003376 quercetin decreases expression ISO RGD:731339 6480464 Quercetin results in decreased expression of SLC30A1 mRNA CTD PMID:21632981 quinolin-8-ol decreases expression ISO RGD:731339 6480464 Oxyquinoline results in decreased expression of SLC30A1 mRNA CTD PMID:21632981 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of SLC30A1 mRNA CTD PMID:19013527 rotenone increases expression ISO RGD:731339 6480464 Rotenone results in increased expression of SLC30A1 mRNA CTD PMID:33512557 SB 431542 multiple interactions ISO RGD:731339 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO RGD:62211 6480464 Silicon Dioxide results in increased expression of SLC30A1 mRNA CTD PMID:19073995 silver atom increases expression ISO RGD:731339 6480464 Silver results in increased expression of SLC30A1 mRNA CTD PMID:26014281 , PMID:28959546 silver atom increases expression ISO RGD:62211 6480464 Silver results in increased expression of SLC30A1 mRNA CTD PMID:27131904 silver(0) increases expression ISO RGD:731339 6480464 Silver results in increased expression of SLC30A1 mRNA CTD PMID:26014281 , PMID:28959546 silver(0) increases expression ISO RGD:62211 6480464 Silver results in increased expression of SLC30A1 mRNA CTD PMID:27131904 silver(1+) nitrate multiple interactions ISO RGD:731339 6480464 MTF1 mutant form inhibits the reaction [Silver Nitrate results in increased expression of SLC30A1 mRNA] CTD PMID:19733233 silver(1+) nitrate increases expression ISO RGD:731339 6480464 Silver Nitrate results in increased expression of SLC30A1 mRNA CTD PMID:19733233 sodium arsenite increases expression ISO RGD:731339 6480464 sodium arsenite results in increased expression of SLC30A1 mRNA CTD PMID:16966095 , PMID:24516582 sodium arsenite decreases expression ISO RGD:731339 6480464 sodium arsenite results in decreased expression of SLC30A1 mRNA CTD PMID:28595984 , PMID:34032870 sodium arsenite affects methylation ISO RGD:731339 6480464 sodium arsenite affects the methylation of SLC30A1 gene CTD PMID:28589171 spironolactone multiple interactions EXP 6480464 Spironolactone inhibits the reaction [Aldosterone results in increased expression of SLC30A1 mRNA] CTD PMID:19333130 staurosporine multiple interactions ISO RGD:62211 6480464 Staurosporine inhibits the reaction [Zinc Sulfate results in increased expression of SLC30A1 mRNA] CTD PMID:15142038 sulfasalazine decreases expression ISO RGD:62211 6480464 Sulfasalazine results in decreased expression of SLC30A1 mRNA CTD PMID:31830553 sulindac increases expression ISO RGD:731339 6480464 Sulindac results in increased expression of SLC30A1 mRNA CTD PMID:11906190 sunitinib increases expression ISO RGD:731339 6480464 Sunitinib results in increased expression of SLC30A1 mRNA CTD PMID:31533062 testosterone decreases expression ISO RGD:62211 6480464 Testosterone results in decreased expression of SLC30A1 mRNA CTD PMID:20403060 tetraphene increases expression ISO RGD:62211 6480464 benz(a)anthracene results in increased expression of SLC30A1 mRNA CTD PMID:26377693 tetraphene multiple interactions ISO RGD:62211 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC30A1 mRNA CTD PMID:27858113 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of SLC30A1 mRNA CTD PMID:34492290 titanium dioxide decreases expression ISO RGD:62211 6480464 titanium dioxide results in decreased expression of SLC30A1 mRNA CTD PMID:23557971 titanium dioxide multiple interactions ISO RGD:62211 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC30A1 mRNA CTD PMID:29950665 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SLC30A1 mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of SLC30A1 mRNA CTD PMID:25729387 trichostatin A increases expression ISO RGD:731339 6480464 trichostatin A results in increased expression of SLC30A1 mRNA CTD PMID:24935251 triptonide increases expression ISO RGD:62211 6480464 triptonide results in increased expression of SLC30A1 mRNA CTD PMID:33045310 valproic acid affects expression ISO RGD:731339 6480464 Valproic Acid affects the expression of SLC30A1 mRNA CTD PMID:25979313 valproic acid multiple interactions ISO RGD:731339 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC30A1 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:731339 6480464 Valproic Acid results in increased expression of SLC30A1 mRNA CTD PMID:23179753 more ... vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of SLC30A1 mRNA CTD PMID:23034163 vorinostat increases expression ISO RGD:731339 6480464 vorinostat results in increased expression of SLC30A1 mRNA CTD PMID:27188386 zidovudine increases expression ISO RGD:731339 6480464 Zidovudine results in increased expression of SLC30A1 mRNA CTD PMID:24292225 zinc acetate multiple interactions ISO RGD:731339 6480464 motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of SLC30A1 mRNA], Zinc Acetate affects the reaction [motexafin gadolinium results in increased expression of SLC30A1 mRNA] CTD PMID:16357179 zinc acetate increases expression ISO RGD:731339 6480464 Zinc Acetate results in increased expression of SLC30A1 mRNA CTD PMID:16357179 zinc atom affects expression EXP 6480464 Zinc affects the expression of SLC30A1 mRNA CTD PMID:15867272 zinc atom increases expression EXP 6480464 Zinc results in increased expression of SLC30A1 mRNA, Zinc results in increased expression of SLC30A1 protein CTD PMID:15378655 more ... zinc atom increases expression ISO RGD:731339 6480464 Zinc results in increased expression of SLC30A1 mRNA, Zinc results in increased expression of SLC30A1 protein CTD PMID:14568174 more ... zinc atom increases uptake ISO RGD:731339 6480464 SLC30A1 protein results in increased uptake of Zinc CTD PMID:18615482 zinc atom decreases expression EXP 6480464 Zinc deficiency results in decreased expression of SLC30A1 protein CTD PMID:12421840 zinc atom affects localization EXP 6480464 Zinc affects the localization of SLC30A1 protein CTD PMID:21636019 zinc atom decreases response to substance EXP 6480464 SLC30A1 mRNA results in decreased susceptibility to Zinc more ... CTD PMID:15378655 more ... zinc atom affects transport EXP 6480464 SLC30A1 protein affects the transport of Zinc CTD PMID:21775119 zinc atom multiple interactions EXP 6480464 Pentetic Acid affects the reaction [SLC30A1 protein affects the transport of Zinc] more ... CTD PMID:15041749 , PMID:21775119 zinc atom decreases expression ISO RGD:62211 6480464 Zinc deficiency results in decreased expression of SLC30A1, Zinc deficiency results in decreased expression of SLC30A1 protein CTD PMID:18936201 , PMID:19492079 zinc atom decreases expression ISO RGD:731339 6480464 Zinc deficiency results in decreased expression of SLC30A1 mRNA more ... CTD PMID:15753530 more ... zinc atom increases expression ISO RGD:62211 6480464 Zinc results in increased expression of SLC30A1, Zinc results in increased expression of SLC30A1 mRNA CTD PMID:19288494 , PMID:20133611 zinc atom decreases uptake ISO RGD:62211 6480464 SLC30A1 protein results in decreased uptake of Zinc CTD PMID:19288494 zinc atom multiple interactions ISO RGD:62211 6480464 [MT1 protein co-treated with MT2 protein] inhibits the reaction [SLC30A1 gene mutant form results in increased susceptibility to Zinc] more ... CTD PMID:15041749 , PMID:19288494 zinc atom increases transport ISO RGD:731339 6480464 SLC30A1 protein results in increased transport of Zinc CTD PMID:18326752 zinc atom multiple interactions ISO RGD:731339 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of SLC30A1 mRNA more ... CTD PMID:15867382 more ... zinc dichloride multiple interactions ISO RGD:731339 6480464 epigallocatechin gallate inhibits the reaction [zinc chloride results in increased expression of SLC30A1 mRNA], zinc chloride inhibits the reaction [Grape Seed Proanthocyanidins results in decreased expression of SLC30A1 mRNA] CTD PMID:20471814 zinc dichloride multiple interactions EXP 6480464 zinc chloride affects the reaction [Cadmium Chloride affects the expression of SLC30A1 mRNA], zinc chloride promotes the reaction [Glucose results in increased expression of SLC30A1 mRNA] CTD PMID:23056475 , PMID:25653005 zinc dichloride increases expression EXP 6480464 zinc chloride results in increased expression of SLC30A1 mRNA CTD PMID:20392624 zinc dichloride increases expression ISO RGD:731339 6480464 zinc chloride results in increased expression of SLC30A1 mRNA CTD PMID:18947441 more ... zinc oxide increases expression ISO RGD:731339 6480464 Zinc Oxide results in increased expression of SLC30A1 mRNA CTD PMID:29289694 zinc oxide increases expression ISO RGD:62211 6480464 Zinc Oxide results in increased expression of SLC30A1 mRNA CTD PMID:33599401 zinc sulfate multiple interactions ISO RGD:731339 6480464 MTF1 mutant form inhibits the reaction [Zinc Sulfate results in increased expression of SLC30A1 mRNA] more ... CTD PMID:17018880 , PMID:21883094 zinc sulfate increases expression ISO RGD:731339 6480464 Zinc Sulfate results in increased expression of SLC30A1 mRNA, Zinc Sulfate results in increased expression of SLC30A1 protein CTD PMID:12756304 more ... zinc sulfate increases expression EXP 6480464 Zinc Sulfate results in increased expression of SLC30A1 mRNA, Zinc Sulfate results in increased expression of SLC30A1 protein CTD PMID:11208937 more ... zinc sulfate decreases expression EXP 6480464 Zinc Sulfate deficiency results in decreased expression of SLC30A1 mRNA CTD PMID:11208937 zinc sulfate increases expression ISO RGD:62211 6480464 Zinc Sulfate results in increased expression of SLC30A1 mRNA CTD PMID:10952993 more ... zinc sulfate affects localization ISO RGD:62211 6480464 Zinc Sulfate affects the localization of SLC30A1 protein CTD PMID:14608047 zinc sulfate multiple interactions ISO RGD:62211 6480464 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Zinc Sulfate results in increased expression of SLC30A1 mRNA] more ... CTD PMID:15142038 zinc sulfate decreases expression ISO RGD:62211 6480464 Zinc Sulfate deficiency results in decreased expression of SLC30A1 mRNA CTD PMID:10952993 zinc(0) affects expression EXP 6480464 Zinc affects the expression of SLC30A1 mRNA CTD PMID:15867272 zinc(0) multiple interactions ISO RGD:731339 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of SLC30A1 mRNA more ... CTD PMID:15867382 more ... zinc(0) increases transport ISO RGD:731339 6480464 SLC30A1 protein results in increased transport of Zinc CTD PMID:18326752 zinc(0) multiple interactions ISO RGD:62211 6480464 [MT1 protein co-treated with MT2 protein] inhibits the reaction [SLC30A1 gene mutant form results in increased susceptibility to Zinc] more ... CTD PMID:15041749 , PMID:19288494 zinc(0) decreases uptake ISO RGD:62211 6480464 SLC30A1 protein results in decreased uptake of Zinc CTD PMID:19288494 zinc(0) increases expression ISO RGD:62211 6480464 Zinc results in increased expression of SLC30A1, Zinc results in increased expression of SLC30A1 mRNA CTD PMID:19288494 , PMID:20133611 zinc(0) decreases expression ISO RGD:731339 6480464 Zinc deficiency results in decreased expression of SLC30A1 mRNA more ... CTD PMID:15753530 more ... zinc(0) decreases expression ISO RGD:62211 6480464 Zinc deficiency results in decreased expression of SLC30A1, Zinc deficiency results in decreased expression of SLC30A1 protein CTD PMID:18936201 , PMID:19492079 zinc(0) multiple interactions EXP 6480464 Pentetic Acid affects the reaction [SLC30A1 protein affects the transport of Zinc] more ... CTD PMID:15041749 , PMID:21775119 zinc(0) affects transport EXP 6480464 SLC30A1 protein affects the transport of Zinc CTD PMID:21775119 zinc(0) decreases response to substance EXP 6480464 SLC30A1 mRNA results in decreased susceptibility to Zinc more ... CTD PMID:15378655 more ... zinc(0) affects localization EXP 6480464 Zinc affects the localization of SLC30A1 protein CTD PMID:21636019 zinc(0) decreases expression EXP 6480464 Zinc deficiency results in decreased expression of SLC30A1 protein CTD PMID:12421840 zinc(0) increases uptake ISO RGD:731339 6480464 SLC30A1 protein results in increased uptake of Zinc CTD PMID:18615482 zinc(0) increases expression ISO RGD:731339 6480464 Zinc results in increased expression of SLC30A1 mRNA, Zinc results in increased expression of SLC30A1 protein CTD PMID:14568174 more ... zinc(0) increases expression EXP 6480464 Zinc results in increased expression of SLC30A1 mRNA, Zinc results in increased expression of SLC30A1 protein CTD PMID:15378655 more ... ziram increases expression ISO RGD:731339 6480464 Ziram results in increased expression of SLC30A1 mRNA CTD PMID:32870474